SCHEMBL16716335

SCHEMBL16716335

CC(=O)C(COS(C)(=O)=O)CC1CO[C@H](c2ccccc2)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19047014 0.71 TSHR (0.37) —
SCHEMBL13377720 0.64 MEN1 (0.36) —
SCHEMBL21597984 0.61 TSHR (0.41) —
SCHEMBL6154118 0.61 CYP1A2 (0.59) —
SCHEMBL6154367 0.61 CYP1A2 (0.59) —
SCHEMBL6427020 0.61 CYP1A2 (0.59) —
SCHEMBL2383804 0.60 TDP1 (0.35) —
SCHEMBL2383807 0.60 TDP1 (0.35) —
SCHEMBL19281761 0.60 MME (0.60) —
SCHEMBL2541606 0.60 LMNA (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007789-B1 Spirocyclic HCV/HIV inhibitors and their uses NOVARTIS AG (CH) 2015-05-20 — — EP disclosed
Send feedback